U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810946) titled 'Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients' on Aug. 26.
Brief Summary: Alcohol withdrawal syndrome is a highly morbid condition affecting a substantial percentage of patients hospitalized who have alcohol use disorders, estimated at 5-6% of all hospitalized patients. Standard treatment paradigms for alcohol withdrawal syndrome have common and serious side effects, and do not fully address this condition's underlying pathophysiology.
This study will examine the feasibility and safety of administering intravenous acetate, an alcohol metabolite and alternative brain fuel, as an adju...